Hormonal Therapy is Out for Meningiomas: Time to Change Tactics?

A Journal of Clinical Oncology podcast by Elizabeth Maher, MD
Originally published Nov. 2, 2015

The randomized placebo controlled trial of progesterone receptor blockade showed no difference in survival, finally answering the question about hormonal therapy in this disease and raising new questions about how to move forward quickly.

Read the associated abstract by Ji, et al: http://jco.ascopubs.org/lookup/doi/10.1200/JCO.2015.61.6490

Subscribe for more podcasts from JCO and JOP, and updates from ASCO
Learn more about the Journal of Clinical Oncology: http://jco.ascopubs.org/